Table 2 Comparison of prognostic indicators in the TBI group and the TBI + Lyc group. CRP C-reactive protein, PCT procalcitonin, GCS Glasgow coma Scale, SOFA sequential organ failure assessment, APACHE II, acute physiology and chronic health evaluation II, GOS Glasgow outcome Scale.
TBI group (n = 35) | TBI + Lyc group (n = 32) | P value | |
|---|---|---|---|
CRP (mg/L), median (IQR) | 45.89 (20.15, 79.95) | 27.85 (11.88, 50.73) | 0.022 |
PCT (ng/mL), median (IQR) | 0.27 (0.09, 0.49) | 0.09 (0.05, 0.15) | 0.001 |
Gastrointestinal complication, n (%) | 22.00 (62.86%) | 8.00 (25.00%) | 0.002 |
Intestinal function assessment | |||
Gastrointestinal function score | |||
Grade 0, n (%) | 3.00 (8.57%) | 9.00 (28.12%) | 0.037 |
Grade I, n (%) | 6.00 (17.14%) | 9.00 (28.12%) | 0.281 |
Grade II, n (%) | 20.00 (57.14%) | 10.00 (31.25%) | 0.033 |
Grade III, n (%) | 4.00 (11.43%) | 3.00 (9.38%) | 1.000 |
Grade IV, n (%) | 2.00 (5.71%) | 1.00 (3.13%) | 1.000 |
Ultrasound (scores), median (IQR) | 3.00 (2.00, 4.00) | 2.00 (0.00, 3.00) | 0.005 |
Neurological deficit assessment | |||
Helsinki CT (scores), median (IQR) | 2.00 (2.00, 4.00) | 2.00 (1.25, 2.00) | 0.335 |
GCS (scores), median (IQR) | 7.00 (4.00, 12.00) | 15.00 (5.25, 15.00) | 0.022 |
SOFA (scores), median (IQR) | 5.00 (2.00, 7.00) | 3.50 (1.00, 5.75) | 0.083 |
APACHE II (scores), (mean ± SD) | 17.31 ± 9.58 | 13.91 ± 7.80 | 0.117 |
Mortality risk (%), median (IQR) | 19.88 (8.20, 37.50) | 15.66 (7.86, 33.98) | 0.444 |
Length of ICU stay (days), median (IQR) | 19.00 (11.00, 30.00) | 13.00 (5.00, 17.00) | 0.002 |
Total hospital stay (days), median (IQR) | 32.00 (24.00, 44.00) | 23.00 (17.00, 29.75) | 0.001 |
28-day mortality, n (%) | 6.00 (17.14%) | 3.00 (9.38%) | 0.567 |
Clinical outcomes, n (%) | 8.00 (22.86%) | 3.00 (9.38%) | 0.137 |
GOS (scores), median (IQR) | 3.00 (2.00, 5.00) | 4.00 (3.00, 5.00) | 0.053 |
